Regeneron, Sanofi Announce FDA Has Accepted For Review BLA For Sarilumab

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (ADR) (NYSE: SNY) jointly announced Friday morning that the U.S. Food and ...